Patients with biallelic variants in TRIM63 and KLHL24 had a relatively mild disease course, PPP1R13L, PPA2 and RPL3L were associated with lethal outcomes at young ages, while ALPK3 and NRAP cases had intermediate outcomes despite often presenting as pediatric CM. This evidence concerns the gene PPA2 and cutaneous mastocytosis.